Survival analysis according to CEBPA mutation status (CEBPA^bi, CEBPA^smTAD, CEBPA^smbZIP, and CEBPA^wt) within the cohort of 4461 patients receiving intensive treatment. Kaplan-Meier plots showing OS (A) and EFS (B). Numbers of patients at risk and results of log-rank tests from pairwise comparisons are provided below the x-axis.